Diagnostic and prognostic value of pentraxin-3 in pulmonary thromboembolism
R. Bayler (Ankara, Turkey), S. Sarinc Ulasli (Ankara, Turkey), A. Batur (Ankara, Turkey), F. Tekin (Van, Turkey), G. Durhan (Ankara, Turkey), Z. Dikmen (Ankara, Turkey), S. Karahan (Ankara, Turkey), Y. Sener (Ankara, Turkey), A. Aksan (Hakkari, Turkey), M. Yilmaz (Ankara, Turkey), E. Babaoglu (Ankara, Turkey), E. Kaya (Ankara, Turkey), D. Koksal (Ankara, Turkey)
Source: International Congress 2022 – Pulmonary embolism: acute and long-term management
Session: Pulmonary embolism: acute and long-term management
Session type: Oral Presentation
Number: 3127
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Bayler (Ankara, Turkey), S. Sarinc Ulasli (Ankara, Turkey), A. Batur (Ankara, Turkey), F. Tekin (Van, Turkey), G. Durhan (Ankara, Turkey), Z. Dikmen (Ankara, Turkey), S. Karahan (Ankara, Turkey), Y. Sener (Ankara, Turkey), A. Aksan (Hakkari, Turkey), M. Yilmaz (Ankara, Turkey), E. Babaoglu (Ankara, Turkey), E. Kaya (Ankara, Turkey), D. Koksal (Ankara, Turkey). Diagnostic and prognostic value of pentraxin-3 in pulmonary thromboembolism. 3127
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|